Cresco Labs Dividend
Dividend criteria checks 0/6
Cresco Labs does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -CA$0.50 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41
Mar 16
Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%
Mar 03Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt
Jan 26Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)
Jan 04Is Cresco Labs (CSE:CL) Using Too Much Debt?
Sep 22Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%
Aug 11Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet
Jan 25Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?
Dec 13We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt
Aug 22Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)
May 23Cresco Labs Inc. (CSE:CL) Analysts Are Way More Bearish Than They Used To Be
Mar 24Estimating The Fair Value Of Cresco Labs Inc. (CSE:CL)
Feb 02Cresco Labs Inc. (CSE:CL) Shares Could Be 41% Below Their Intrinsic Value Estimate
Oct 27Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt
Oct 06Cresco Labs Inc. (CSE:CL) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
Mar 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CL's dividend payments have been increasing.
Dividend Yield vs Market
| Cresco Labs Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CL) | n/a |
| Market Bottom 25% (CA) | 1.9% |
| Market Top 25% (CA) | 6.5% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast in 3 Years (CL) | n/a |
Notable Dividend: Unable to evaluate CL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CL has not reported any payouts.